Clinical trial
Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer
NCT07242911 is registered in ClinicalTrials.gov with Chifeng Tumor Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer
- Lead sponsor
- Chifeng Tumor Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- August 1, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ppancreatic cancer